A Community Approach to Boost Cervical Cancer Screening for Hispanic and East African Immigrant Women

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This interventional study targets cervical cancer screening among women who identify as Hispanic or East African immigrants. The approach combines a self-collection HPV test with an informational intervention and interviews to understand barriers and preferences. Participants will be 30 to 65 years old, have an intact uterus, and have limited recent screening history. The trial is conducted at Mayo Clinic in Rochester and measures changes in screening uptake and user experience. Results may inform scalable community-based strategies to increase access to HPV-based screening.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Females self-identifying as belonging to the Hispanic or East African immigrant community
* Ages 30-65 years
* Intact uterus

Exclusion Criteria:

* Females who do not identify as belonging to the Hispanic or East African immigrant community
* Outside age range of 30-65 years
* Self reported history of

  * Hysterectomy
  * Cervical cancer
  * Cervical cancer screening in the last 3 years
  * Current pregnancy or post-partum in the last 3 months
  * Positive HIV status
  * Immunocompromise
  * Use of vaginal products within 2 days of appointment

Where it's running

• Mayo Clinic in Rochester
  Rochester, Minnesota, United States Recruiting

Study contacts

• Principal investigator: Jissy Cyriac, MD — Mayo Clinic in Rochester
• Study coordinator: Clinical Trials Referral Office
• Email: mayocliniccancerstudies@mayo.edu
• Phone: 855-776-0015

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Flyte device to help urinary incontinence after pelvic radiation for endometrial or cervical cancer

  This study tests whether a home-use Flyte device, used during guided pelvic floor exercises, can improve urinary incontinence in women who had pelvic radiation for endometrial or cervical cancer.

  Recruiting Mayo Clinic · Rochester, Minnesota · NCT07662824

• Neoadjuvant nivolumab for cervical cancer using tumor-draining lymph nodes

  This study tests different doses of nivolumab injected near the tumor to see if the treatment is safe and feasible before standard surgery in newly diagnosed cervical cancer.

  Recruiting Phase 1 University Medical Center Groningen · Groningen · NCT07653503

• Vaginal DHEA to improve vaginal health after pelvic radiation

  This phase II trial tests whether daily vaginal DHEA can help reduce vaginal dryness, pain, and related symptoms in menopausal women after radiation for gynecologic, anal, or rectal cancers.

  Recruiting Phase 2 Ohio State University Comprehensive Cancer Center · Columbus, Ohio · NCT07407647

• In-home cancer treatment with remote specialist support for patients in the Florida Panhandle

  This program will try giving standard cancer treatments at home to people living in the Florida Panhandle and nearby areas to see if they prefer it and have better treatment satisfaction.

  Recruiting Phase 2 Mayo Clinic · Jacksonville, Florida · NCT07285044

• Self-collected HPV testing to help prevent cervical cancer

  This trial tests whether people referred for colposcopy can collect their own vaginal sample for HPV testing and whether those self-samples match clinician-collected cervical samples.

  Recruiting at 18 sites National Cancer Institute (NCI) · Birmingham, Alabama and 17 other locations · NCT07281430

• Detecting double-positive (tumor marker/CD45+) cells in the blood of people with metastatic cancer

  This one-day study will test two blood-based methods to find double-positive tumor/CD45+ circulating cells in adults who are about to start treatment for various metastatic cancers.

  Recruiting Institut Claudius Regaud · Toulouse · NCT06967961

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.